-
公开(公告)号:US20110251164A1
公开(公告)日:2011-10-13
申请号:US12828732
申请日:2010-07-01
IPC分类号: A61K31/58 , A61K31/423 , A61P11/00 , A61K31/397 , A61K31/56 , A61P11/06 , A61K31/40 , A61K31/445
CPC分类号: C07D207/12 , C07D205/02 , C07D205/04 , C07D207/04 , C07D211/26 , C07D211/46 , C07D413/12
摘要: The invention relates to compounds of formula processes and intermediates for their preparation, their use as muscarinic antagonists and pharmaceutical composition containing them.
摘要翻译: 本发明涉及式的化合物及其制备中间体,它们用作毒蕈碱性拮抗剂和含有它们的药物组合物。
-
公开(公告)号:US20090227680A1
公开(公告)日:2009-09-10
申请号:US12093503
申请日:2006-11-06
申请人: Simon John Mantell
发明人: Simon John Mantell
IPC分类号: A61K31/195 , C07C62/00
CPC分类号: C07C229/22
摘要: The present invention relates to a method of treating pain using a compound of formula (I), wherein Ar, R1, R3 and R3a are as defined herein. The invention also relates to certain novel compounds of formula (I).
摘要翻译: 本发明涉及使用式(I)化合物治疗疼痛的方法,其中Ar,R 1,R 3和R 3a如本文所定义。 本发明还涉及某些新的式(I)化合物。
-
公开(公告)号:US6048864A
公开(公告)日:2000-04-11
申请号:US67588
申请日:1998-04-28
IPC分类号: A61K31/47 , A61K31/4709 , A61K31/4725 , A61K31/505 , A61K31/535 , A61K31/55 , A61K31/551 , A61P13/02 , A61P13/08 , A61P15/00 , C07D401/04 , C07D403/04 , C07D405/14 , C07D471/04 , C07D239/94 , C07D239/95
CPC分类号: C07D401/04 , C07D403/04 , C07D405/14
摘要: Compounds of formula I, ##STR1## wherein R.sup.1 represents C.sub.1-4 alkoxy optionally substituted by one or more fluorine atoms;R.sup.2 and R.sup.3 independently represent H or C.sub.1-6 alkoxy (which is optionally substituted);R.sup.4 represents a 4-, 5-, 6- or 7-membered heterocyclic ring, the ring being optionally fused to a benzene ring or a 5- or 6-membered heterocyclic, the ring system as a whole being optionally substituted;X represents CH or N; andL is absent,or represents a cyclic group of formula Ia, ##STR2## or represents a chain of formula Ib, ##STR3## and pharmaceutically acceptable salts thereof, are useful in therapy, in particular in the treatment of benign prostatic hyperplasia.
摘要翻译: 式I化合物,其中R 1表示任选被一个或多个氟原子取代的C 1-4烷氧基; R2和R3独立地表示H或C1-6烷氧基(其任选被取代); R4表示4-,5-,6-或7-元杂环,该环任选地与苯环或5-或6-元杂环稠合,该环系统作为整体任选被取代; X表示CH或N; 并且L不存在,或表示式Ia的环状基团,或表示式Ib的链及其药学上可接受的盐可用于治疗,特别是治疗良性前列腺增生。
-
公开(公告)号:US08486992B2
公开(公告)日:2013-07-16
申请号:US12828732
申请日:2010-07-01
IPC分类号: A61K31/40 , A61K31/423 , A61K31/445
CPC分类号: C07D207/12 , C07D205/02 , C07D205/04 , C07D207/04 , C07D211/26 , C07D211/46 , C07D413/12
摘要: The invention relates to compounds of formula processes and intermediates for their preparation, their use as muscarinic antagonists and pharmaceutical composition containing them.
摘要翻译: 本发明涉及式的化合物及其制备中间体,它们用作毒蕈碱性拮抗剂和含有它们的药物组合物。
-
公开(公告)号:US08268881B2
公开(公告)日:2012-09-18
申请号:US12556285
申请日:2009-09-09
IPC分类号: A61K31/40 , C07D295/22
CPC分类号: C07D207/12 , C07D205/02 , C07D205/04 , C07D207/04 , C07D211/26 , C07D211/46 , C07D413/12
摘要: The invention relates to compounds of formula processes and intermediates for their preparation, their use as muscarinic antagonists and pharmaceutical composition containing them.
摘要翻译: 本发明涉及式的化合物及其制备中间体,它们用作毒蕈碱性拮抗剂和含有它们的药物组合物。
-
公开(公告)号:US20110306597A1
公开(公告)日:2011-12-15
申请号:US12997987
申请日:2009-06-12
申请人: James Michael Crawforth , Paul Alan Glossop , Bruce Cameron Hamper , Wei Huang , Bradley Elwood Neal , Simon John Mantell , Kirk Olson , Atli Thorarensen , Steve Ronald Turner
发明人: James Michael Crawforth , Paul Alan Glossop , Bruce Cameron Hamper , Wei Huang , Bradley Elwood Neal , Simon John Mantell , Kirk Olson , Atli Thorarensen , Steve Ronald Turner
IPC分类号: A61K31/55 , A61K31/437 , C07D417/12 , A61K31/4439 , C07D401/12 , A61K31/444 , C07D487/04 , A61K31/519 , C07D413/14 , A61K31/5377 , C07D213/82 , A61K31/44 , C07D413/12 , A61K31/5355 , C07D451/02 , A61K31/46 , A61P11/00 , A61P37/08 , A61P11/06 , C07D471/04
CPC分类号: C07D471/04 , C07D213/81 , C07D213/82 , C07D401/12 , C07D401/14 , C07D405/12 , C07D413/12 , C07D417/12 , C07D451/04 , C07D471/08 , C07D487/04
摘要: The present invention relates to compounds of the formula (I) and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are defined herein, to compositions containing such compounds and to the uses of such compounds for the treatment of allergic and respiratory conditions.
摘要翻译: 本发明涉及式(I)化合物及其药学上可接受的盐和溶剂合物,其中取代基在本文中定义为含有这些化合物的组合物以及这些化合物用于治疗过敏和呼吸病症的用途。
-
公开(公告)号:US20100029720A1
公开(公告)日:2010-02-04
申请号:US12556285
申请日:2009-09-09
IPC分类号: A61K31/423 , C07D207/12 , C07D413/12 , C07D211/44 , A61K31/4015 , A61K31/45 , A61P11/00 , A61P29/00
CPC分类号: C07D207/12 , C07D205/02 , C07D205/04 , C07D207/04 , C07D211/26 , C07D211/46 , C07D413/12
摘要: The invention relates to compounds of formula processes and intermediates for their preparation, their use as muscarinic antagonists and pharmaceutical composition containing them.
摘要翻译: 本发明涉及式的化合物及其制备中间体,它们用作毒蕈碱性拮抗剂和含有它们的药物组合物。
-
公开(公告)号:US07238676B2
公开(公告)日:2007-07-03
申请号:US10869380
申请日:2004-06-15
IPC分类号: A61K31/70 , A61K31/7076 , C07H19/167
CPC分类号: C07H19/16 , Y10S514/825 , Y10S514/861
摘要: The present invention relates to compounds of the formula and pharmaceutically acceptable salts and solvates thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds as adenosine A2a receptor agonists.
摘要翻译: 本发明涉及下式的化合物及其药学上可接受的盐和溶剂化物,其制备方法,用于制备的中间体和含有这些化合物的组合物以及这些化合物如腺苷A2a受体激动剂的用途。
-
公开(公告)号:US06921753B2
公开(公告)日:2005-07-26
申请号:US09884244
申请日:2001-06-19
IPC分类号: C07H19/16 , A61K31/70 , C07H19/167 , C07H19/173
CPC分类号: C07H19/16 , Y10S514/825 , Y10S514/861
摘要: The present invention relates to compounds of the formula and pharmaceutically acceptable salts and solvates thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds as adenosine A2a receptor agonists.
摘要翻译: 本发明涉及下式的化合物及其药学上可接受的盐和溶剂合物,其制备方法,用于制备的中间体和含有这些化合物的组合物以及这些化合物如腺苷A2a受体激动剂的用途。
-
公开(公告)号:US06624158B2
公开(公告)日:2003-09-23
申请号:US09933421
申请日:2001-08-20
IPC分类号: C07D47334
CPC分类号: C07H19/16
摘要: The present invention relates to compounds of the formula and pharmaceutically acceptable salts and solvates thereof, wherein R2 is —CH2NHSO2—A—R3, —CONR10—A1—R11, —X—NR12a—Y—NR13R14 or —CO—NR18—X1—NR12—Y—NR13R14; R19, where R19 is a C-linked, 5-membered aromatic heterocycle containing either (i) from 1 to 4 ring nitrogen atoms or (ii) 1 or 2 ring nitrogen atoms and 1 oxygen or 1 sulphur ring atom, said heterocycle being optionally substituted by C1-C6 alkyl, said C1-C6 alkyl being optionally substituted by phenyl, —OH, C1-C6 alkoxy or —NR20R21 and R1, A, R3, R10, R11, X, R12a, Y, R13, R14, R18, X1, R21 and R22 are as defined in the specification. The invention also relates to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds as adenosine A2a receptor agonists. The invention is particularly related to methods of treating respiratory diseases such as adult respiratory distress syndrome, bronchitis, chronic bronchitis, chronic obstructive pulmonary disease, cystic fibrosis, asthma, emphysema bronchiectasis, chronic sinusitis and rhinitis.
摘要翻译: 本发明涉及式及其药学上可接受的盐和溶剂化物,其中R 2是-CH 2 NHSO 2 -AR 3,-CONR 10 -A 1 -R 11,-X-NR -Y-NR 13 R 14或-CO-NR 18 -X 1 -NR 12 -Y-NR 13 R 14; 其中R 19是含有(i)1至4个环氮原子或(ii)1或2个环氮原子和1个氧或1个硫环的C连接的5元芳族杂环 所述杂环任选被C 1 -C 6烷基取代,所述C 1 -C 6烷基任选被苯基,-OH,C 1 -C 6烷氧基或-NR 20 R 21和R 1取代,A,R R 10,R 11,X,R 12a,Y,R 13,R 14,R 18,X 1,R 21和R 11, 22>如说明书中所定义。 本发明还涉及用于制备用于制备中间体的方法和含有这些化合物的组合物以及这些化合物作为腺苷A2a受体激动剂的用途。 本发明特别涉及治疗呼吸系统疾病如成人呼吸窘迫综合征,支气管炎,慢性支气管炎,慢性阻塞性肺病,囊性纤维化,哮喘,肺气肿支气管扩张,慢性鼻窦炎和鼻炎的方法。
-
-
-
-
-
-
-
-
-